Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
It has been suggested that metformin displays potential beneficial effects by reducing several cardiovascular dysfunction risk factors, such as body mass index (BMI) (MD: 0.53 kg/m 2 , 95% CI 0.95, 0.12), insulin-resistance (HOMA-IR) (MD:0.50, 95% CI 0.91, 0.09), triglyceride (MD: 0.11 mmol/L, 95% CI 0.20, 0.02), plasma plasminogen activator inhibitor-1 (Ruth, Day et al.) (MD: 4.99 ng/mL, 95% CI 6.78, 3.21) (Li and Li, 2023), carotid intima-media thickness (CIMT), and flow-mediated dilation (FMD) (Wang et al., 2024) in PCOS patients
FDA GRAS Notified GRN #000293) resulted in a PGC-1, Mitochondrial DNA and AMP activated-kinase expression in skeletal muscle, which can lead to acceleration of fatty acid utilization through activation of mitochondrial aerobic metabolism
Unlike single-function ingredients, it delivers multi-pathway benefits through regeneration, repair, and biochemical signaling
Patients who invest time in this preparation phase consistently report fewer side effects and better sustained outcomes than those who begin treatment unprepared
BPC 157 $42.00 $62.00Price range: $42.00 through $62.00 BPC-157 BPC-157 (Body Protection Compound) 5mg (Lyophilized Peptide) For Research Use Only BPC-157 is a synthetic peptide fragment derived from a protective protein found in the human gastric system
US$ 27.89
US$ 26.07
US$ 23.48
US$ 28.28
US$ 25.93
US$ 29.56
US$ 28.76